Bevacizumab Biosimilar 400mg Injection – Global Supply by Cordium Pharmaceuticals Pvt Ltd
Description
Product Overview
Bevacizumab Biosimilar 400mg Injection is a targeted anti-cancer therapy widely used in oncology treatment protocols. Manufactured and exported by Cordium Pharmaceuticals Pvt Ltd, this biosimilar offers high quality, cost-effective treatment solutions for international healthcare providers, hospitals, and distributors.
Cordium Pharmaceuticals is recognized as a leading pharmaceutical exporter in India, ensuring reliable global delivery with strict quality compliance and fast shipping.
Key Features
Generic Name: Bevacizumab Biosimilar
Strength: 400 mg Injection
Dosage Form: Injectable (IV Infusion)
Therapeutic Class: Anti-VEGF Monoclonal Antibody
Packaging: Export-grade secure packaging
Quality Compliance: WHO-GMP standards
Medical Uses
Bevacizumab is commonly prescribed for the treatment of various cancers, including:
Colorectal Cancer
Non-Small Cell Lung Cancer
Kidney Cancer
Cervical Cancer
Ovarian Cancer
This biosimilar works by inhibiting angiogenesis (blood vessel formation), helping to slow or stop tumor growth.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global oncology medicine exporter from India
Competitive pricing for bulk and wholesale buyers
Fast and secure international shipping
Reliable supply chain for hospitals and distributors
Regulatory-compliant export documentation
Global Export Markets
We supply Bevacizumab Biosimilar 400mg Injection with fast shipping to:
USA: Washington, New York, San Francisco
Philippines
United Kingdom: London, Birmingham, Manchester
South Africa
UAE: Dubai, Abu Dhabi, Oman, Qatar
Canada
Singapore
Packaging & Shipping
Temperature-controlled logistics available
Safe, tamper-proof export packaging
Express international courier options
Real-time shipment tracking
Bulk Orders & Enquiries
For bulk orders, hospital supply, or distributor partnerships, contact Cordium Pharmaceuticals Pvt Ltd today for competitive quotes and fast dispatch.
